Melanocortin agonist for sexual desire and arousal — men and women.
PT-141 (bremelanotide) is a melanocortin-receptor agonist that acts centrally on desire and arousal. Unlike PDE5 inhibitors, it works through the CNS rather than vascular pathways.
Subcutaneous injection 45–60 minutes prior to intimacy; effect lasts 6–24 hours.
Agonist of MC3R/MC4R receptors in the CNS, modulating desire circuits.
Can cause transient nausea, flushing and blood-pressure elevation. Discuss with physician if cardiovascular disease.
This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.
PT-141 acts on desire in the brain; PDE5s act on vascular response.
Sometimes yes — under physician supervision.
45–60 minutes.
Blood pressure recommended early in therapy.
GHRH analog that stimulates your body's own growth hormone in a physiologic pattern.
Long-acting GHRH analog often paired with Ipamorelin for GH optimization.
Selective GH secretagogue with minimal impact on cortisol, prolactin or appetite.
Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.
